These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8798412)

  • 1. Transmembrane regions V and VI of the human luteinizing hormone receptor are required for constitutive activation by a mutation in the third intracellular loop.
    Kudo M; Osuga Y; Kobilka BK; Hsueh AJ
    J Biol Chem; 1996 Sep; 271(37):22470-8. PubMed ID: 8798412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A study on the role of the transmembrane V to VI regions of the human luteinizing hormone receptor in its constitutive activation].
    Kudo M
    Hokkaido Igaku Zasshi; 1999 Jan; 74(1):53-65. PubMed ID: 10331060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The C-terminal third of the human luteinizing hormone (LH) receptor is important for inositol phosphate release: analysis using chimeric human LH/follicle-stimulating hormone receptors.
    Hirsch B; Kudo M; Naro F; Conti M; Hsueh AJ
    Mol Endocrinol; 1996 Sep; 10(9):1127-37. PubMed ID: 8885247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mutation of the luteinizing hormone receptor gene causing male gonadotropin-independent precocious puberty.
    Latronico AC; Anasti J; Arnhold IJ; Mendonça BB; Domenice S; Albano MC; Zachman K; Wajchenberg BL; Tsigos C
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2490-4. PubMed ID: 7629248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the luteinizing hormone receptor following substitution of Ser-277 with selective hydrophobic residues in the ectodomain hinge region.
    Nakabayashi K; Kudo M; Kobilka B; Hsueh AJ
    J Biol Chem; 2000 Sep; 275(39):30264-71. PubMed ID: 10889210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A sporadic case of male-limited precocious puberty has the same constitutively activating point mutation in luteinizing hormone/choriogonadotropin receptor gene as familial cases.
    Yano K; Hidaka A; Saji M; Polymeropoulos MH; Okuno A; Kohn LD; Cutler GB
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1818-23. PubMed ID: 7527413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phe576 plays an important role in the secondary structure and intracellular signaling of the human luteinizing hormone/chorionic gonadotropin receptor.
    Yano K; Kohn LD; Saji M; Okuno A; Cutler GB
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2586-91. PubMed ID: 9253338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of extracellular domain peptides of the FSH receptor and their effect on receptor-ligand interactions in vitro.
    Sharma SC; Catterall JF
    Mol Cell Endocrinol; 1995 Nov; 115(1):87-93. PubMed ID: 8674868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nematode leucine-rich repeat-containing, G protein-coupled receptor (LGR) protein homologous to vertebrate gonadotropin and thyrotropin receptors is constitutively active in mammalian cells.
    Kudo M; Chen T; Nakabayashi K; Hsu SY; Hsueh AJ
    Mol Endocrinol; 2000 Feb; 14(2):272-84. PubMed ID: 10674399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposite contribution of two ligand-selective determinants in the N-terminal hormone-binding exodomain of human gonadotropin receptors.
    Vischer HF; Granneman JC; Bogerd J
    Mol Endocrinol; 2003 Oct; 17(10):1972-81. PubMed ID: 12869592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the third intracellular loop for the activation of gonadotropin receptors.
    Schulz A; Schöneberg T; Paschke R; Schultz G; Gudermann T
    Mol Endocrinol; 1999 Feb; 13(2):181-90. PubMed ID: 9973249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor binding and functional properties of chimeric human follitropin prepared by an exchange between a small hydrophilic intercysteine loop of human follitropin and human lutropin.
    Dias JA; Zhang Y; Liu X
    J Biol Chem; 1994 Oct; 269(41):25289-94. PubMed ID: 7929221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new constitutively activating point mutation in the luteinizing hormone/choriogonadotropin receptor gene in cases of male-limited precocious puberty.
    Yano K; Saji M; Hidaka A; Moriya N; Okuno A; Kohn LD; Cutler GB
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1162-8. PubMed ID: 7714085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precocious puberty.
    Laue L; Chan WY; Hsueh AJ; Kudo M; Hsu SY; Wu SM; Blomberg L; Cutler GB
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):1906-10. PubMed ID: 7892197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of distinct activating mutations of the luteinizing hormone receptor gene on the pituitary-gonadal axis in both sexes.
    Latronico AC; Lins TS; Brito VN; Arnhold IJ; Mendonca BB
    Clin Endocrinol (Oxf); 2000 Nov; 53(5):609-13. PubMed ID: 11106922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of gonadotropin receptors Fshr and Lhr in Japanese medaka, Oryzias latipes.
    Burow S; Mizrahi N; Maugars G; von Krogh K; Nourizadeh-Lillabadi R; Hollander-Cohen L; Shpilman M; Atre I; Weltzien FA; Levavi-Sivan B
    Gen Comp Endocrinol; 2020 Jan; 285():113276. PubMed ID: 31536722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeras of the rat and human FSH receptors (FSHRs) identify residues that permit or suppress transmembrane 6 mutation-induced constitutive activation of the FSHR via rearrangements of hydrophobic interactions between helices 6 and 7.
    Tao YX; Mizrachi D; Segaloff DL
    Mol Endocrinol; 2002 Aug; 16(8):1881-92. PubMed ID: 12145341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-expression of defective luteinizing hormone receptor fragments partially reconstitutes ligand-induced signal generation.
    Osuga Y; Hayashi M; Kudo M; Conti M; Kobilka B; Hsueh AJ
    J Biol Chem; 1997 Oct; 272(40):25006-12. PubMed ID: 9312107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive activation of G protein-coupled receptors as a result of selective substitution of a conserved leucine residue in transmembrane helix III.
    Tao YX; Abell AN; Liu X; Nakamura K; Segaloff DL
    Mol Endocrinol; 2000 Aug; 14(8):1272-82. PubMed ID: 10935550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleiotropic effects of substitutions of a highly conserved leucine in transmembrane helix III of the human lutropin/choriogonadotropin receptor with respect to constitutive activation and hormone responsiveness.
    Shinozaki H; Fanelli F; Liu X; Jaquette J; Nakamura K; Segaloff DL
    Mol Endocrinol; 2001 Jun; 15(6):972-84. PubMed ID: 11376115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.